Publication | Closed Access

Direct Medical Costs of Coronary Artery Disease in the United States 11This study was supported in part by Parke-Davis, a division of Warner-Lambert Company, Morris Plains, New Jersey, and Pfizer, Inc., New York, New York.

Cardiovascular EpidemiologyCardiovascular DiseaseHealth EconomicsHealth PolicyMedicineOutcomes ResearchHealth Care CostPreventive CardiologyNew YorkPublic HealthEconomic EvaluationDirect Medical CostsCardiologyEpidemiologyCoronary Artery DiseaseCoronary Heart Disease